• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9610TF29
Device Problems Break (1069); Leak/Splash (1354); Failure to Advance (2524); Material Deformation (2976); Mechanical Jam (2983); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/25/2021
Event Type  malfunction  
Manufacturer Narrative
The device return is in progress.A supplemental report will be submitted upon evaluation completion.
 
Event Description
As reported by our affiliate from finland, a 29mm sapien 3 transcathter valve was implanted during a mitral valve in valve procedure by vena cava vein approach.During the procedure, the commander delivery system (crimped with 29 mm valve) was brought through the esheath to inferior vena cava vein.When doing the valve alignment a bigger resistance in a catheter as normal when doing valve alignment was noticed, but it was possible to finish the alignment using the fine tuning knob, as normally.The valve was between the markers.The procedure continued towards right atrium.When arriving to the atrium, there was a pacemaker lead which stuck between the valve struts when trying to reach trans septal opening.The lead was stuck to the struts quite tight and was very difficult to release.After many attempts to manage to release the lead, the decision was to try to continue through the septum opening.It was not possible to manage to go through the opening and after few attempts, the decision was to cancel and remove the catheter from the patient.There was moderate resistance while removing the ds through the esheath.The entire system was removed through the esheath.When inspecting the commander catheter, it was noticed that the balloon was broken/burst.The balloon leakage was noticed after ds retrieval.A new catheter and a new valve was used and the valve was successfully implanted.The procedure went well and the patient outcome was good.As per medical opinion, what was the root cause of the balloon damage may have been during insertion through the esheath or due to interaction with atrial lead/atrial septal crossing.
 
Manufacturer Narrative
Supplemental report submitted update h6 device code.Per pre decontamination evaluation observations, the balloon torn was found.
 
Manufacturer Narrative
The device was returned for evaluation and an engineering evaluation was performed.The visual inspection of the returned device was performed and the following was observed: valve returned crimped on inflation balloon.Minor flex tip gouges.The crimp balloon was torn proximal to i/c (inflation balloon/crimp balloon) bond.Flex shaft kink located 1.25 inches from the flex tip.Flex shaft compression located 3.5inches from the flex tip.Functional testing of the returned device was performed and full valve alignment (gross and fine adjust) was able to be performed with no issues.With the balloon shaft locked at the valve alignment position, the balloon shaft was able to be pulled to 67.6n without any slipping observed which met specification.The device history record (dhr) was reviewed and the work orders did not reveal any manufacturing nonconformance issues that would have contributed to the complaint event.A lot history review was performed and revealed no other complaints relating to this event.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints for gross alignment difficulty and balloon tear were confirmed based on the provided imagery and condition of the returned device.The complaint for device interferes with permanent pacemaker lead was unable to be confirmed due to unavailability of applicable imagery.However, no manufacturing nonconformance was identified during the evaluation.A review of the dhr, complaint history review and lot history did not provide any indication that a manufacturing non conformance would have contributed to the complaint.A review of the ifu and training manuals revealed no deficiencies.Available information suggests procedural factors (valve alignment in a non straight section of the anatomy / high alignment forces) may have contributed to the reported event.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor pra is required at this time.For the complaint of balloon torn, potential root causes for separation of the inflation balloon to crimp balloon bond have been identified and documented in a product risk assessment (pra).As identified in the pra, high forces on the system during valve alignment may result in crimp balloon tearing prior to thv deployment.Potential sources of high forces, which will impact difficulty with aligning the valve, include performing valve alignment in tortuous vasculature.Performing valve alignment in a non straight section can cause the valve to dive into the lumen of the flex tip where part of the crimped valve slides into the flex tip lumen, as evidenced by the flex tip gouges.If the thv is unseated (non coaxial placement of valve in relation to the flex tip) during alignment, it can result in higher than usual valve alignment forces (as evidenced by the flex shaft compression) and can potentially weaken the crimp balloon and cause tension to the system.Per the training manual, if excessive tension is experienced during valve alignment, repositioning the delivery system to a different straight section of the aorta and relieving compression (or tension) in the system will be necessary.Available information suggests procedural factors (valve alignment in a non straight section of the anatomy / high alignment forces) may have contributed to the reported event.No ifu/labeling/training manual inadequacies were identified.A capa was previously initiated to address this failure mode.The exact cause of pacemaker lead interaction during a transseptal mitral procedure is unknown.However, some possible causes include: suboptimal anchoring of the pacemaker lead, suboptimal/anomalous trajectory of the lead, suboptimal location of the septal puncture (too close to the pacemaker lead).Due to insufficient information provided, a definite root cause is unable to be determined at this time.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action is required at this time.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS COMMANDER DELIVERY SYSTEM
Type of Device
PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key11690989
MDR Text Key248557812
Report Number2015691-2021-02562
Device Sequence Number1
Product Code NPU
UDI-Device Identifier00690103193008
UDI-Public(01)00690103193008(17)221006(10)63435183
Combination Product (y/n)N
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 06/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/06/2022
Device Model Number9610TF29
Device Catalogue NumberN/A
Device Lot Number63435183
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/25/2021
Initial Date FDA Received04/19/2021
Supplement Dates Manufacturer Received05/05/2021
06/28/2021
Supplement Dates FDA Received05/19/2021
06/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age61 YR
-
-